Zymeworks
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zymeworks and other ETFs, options, and stocks.About ZYME
Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2).
CEOKenneth Harry Galbraith
CEOKenneth Harry Galbraith
Employees286
Employees286
HeadquartersMiddletown, Delaware
HeadquartersMiddletown, Delaware
Founded2003
Founded2003
Employees286
Employees286
ZYME Key Statistics
Market cap1.15B
Market cap1.15B
Price-Earnings ratio-15.35
Price-Earnings ratio-15.35
Dividend yield—
Dividend yield—
Average volume499.91K
Average volume499.91K
High today$15.52
High today$15.52
Low today$14.69
Low today$14.69
Open price$15.00
Open price$15.00
Volume508.73K
Volume508.73K
52 Week high$17.70
52 Week high$17.70
52 Week low$9.03
52 Week low$9.03
Analyst ratings
80%
of 10 ratingsBuy
80%
Hold
20%
Sell
0%
People also own
Based on the portfolios of people who own ZYME. This list is generated using Robinhood data, and it’s not a recommendation.